D-0149-2024 Class III
FDA drug recall D-0149-2024 was initiated by Siegfried Barbera, SL on Nov 20, 2023 and is designated Class III. Reason for recall: Failed Dissolution Specifications Affected quantity: 2016.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 20, 2023
- Initiation Date
- Nov 20, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2016
Product description
Votrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, S.L., Barbera del Valles, Spain, Distributed by: Novartis Pharmaceuticals Corp., East Hanover, N.J. 07936, NDC 0078-1077-66
Reason for recall
Failed Dissolution Specifications
Distribution pattern
Nationwide
Code information
Lot# ME2713; Exp. 02/2025 Lot # MF8286, ML1860; Exp. 04/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0149-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026